drugset / Trial / NCT00251758
Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of daily treatment with Dexlansoprazole modified release (MR) (60 mg or 90 mg once daily \[QD\]) compared to placebo QD in relief of daytime and nighttime heartburn over 4 weeks in subjects with gastroesophageal reflux disease (GERD).
Timeline
- Start
- 2005-12
- Primary completion
- 2006-05
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexlansoprazole | Other / unclassified | 60 mg | Oral |
| Subject | Dexlansoprazole | Other / unclassified | 90 mg | Oral |